Le Lézard
Classified in: Business
Subject: ANNUAL MEETINGS

RioCan Real Estate Investment Trust Announces Results of Voting at RioCan's Annual Meeting


TORONTO, May 28, 2019 (GLOBE NEWSWIRE) -- RioCan Real Estate Investment Trust ("RioCan") (TSX: REI.UN) today announced the results of the votes held at its May 28, 2019 Annual Meeting of unitholders (the "Meeting").

The total number of units represented by unitholders present in person or by proxy at the Meeting was 184,869,634; representing 60.86% of RioCan's outstanding units entitled to be voted.

Each of the nominee Trustees listed in the Trust's Management Information Circular dated March 29, 2019 was elected as a Trustee, without a vote by ballot being conducted. RioCan received proxies with regard to voting on the nine Trustees nominated for election, as set forth in the table below:

Name of
Nominee
Votes
For
%Votes
Withheld
%
Bonnie Brooks, C.M.166,510,12390.62%17,232,8799.38%
Richard Dansereau183,550,59799.90%192,4050.10%
Paul Godfrey, C.M., O.Ont.138,734,69275.50%45,008,31024.50%
Dale H. Lastman, C.M.173,518,54494.44%10,224,4585.56%
Jane Marshall183,156,13999.68%586,8630.32%
Sharon Sallows166,024,62390.36%17,718,3799.64%
Edward Sonshine, O.Ont., Q.C.182,634,85599.40%1,108,1470.60%
Siim A. Vanaselja178,088,85096.92%5,654,1523.08%
Charles M. Winograd183,168,81199.69%574,1910.31%

Appointment of Auditors

Ernst & Young LLP, Chartered Accountants, was reappointed as the auditor of the Trust until the next annual meeting of unitholders by resolution passed by a majority of the unitholders. Management received proxies to vote for the appointment of the auditor (and to authorize the Trustees to fix their remuneration) as follows:

Votes
For
 %Votes
Withheld
 %
184,111,15499.70%560,5970.30%

Say-On-Pay Non-Binding Advisory Vote

The non-binding say-on-pay vote on the Trust's approach to executive compensation was passed as follows:

Votes
For
 %Votes
Against
 %
149,657,55581.36%34,283,53018.64%

About RioCan
RioCan is one of Canada's largest real estate investment trusts with a total enterprise value of approximately $14.1 billion at March 31, 2019. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians want to shop, live and work. Our portfolio is comprised of 230 properties, including 14 development properties, with an aggregate net leasable area of approximately 38.3 million square feet including residential rental properties. To learn more about how we deliver real vision on solid ground, visit www.riocan.com.

For more information contact:
Terri Andrianopoulos
VP Marketing & Communications, RioCan REIT
416 646 8138
[email protected]


These press releases may also interest you

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
Bidpath Inc., a leading provider of global online auction software, proudly announces the launch of AuctionPay, a cutting-edge payments platform designed to revolutionize auction payments. With a focus on efficiency, security, and user-centric...

at 08:00
SC Ventures, Standard Chartered's innovation, fintech investment and ventures arm, is leading a ?12 million (USD $13 million) Series A round for distributed cloud provider Hive, to increase access to sustainable, high-powered computing resources for...

at 08:00
Callon Petroleum Company ("Callon" or the "Company") today announced the expiration and final tender results of its previously announced cash tender offers (the "Offers") for any and all of its 8.000% Senior Notes due 2028 (the "2028 Notes") and any...

at 08:00
The parties in Severa, et al. v. Solvay Specialty Polymers USA, LLC, et al., announce that Judge Noel Hillman of the United States District Court for the District of New Jersey has preliminarily approved a class action settlement. The hearing on...

at 08:00
PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical trial of Zolmitriptan PassPort® utilizing its...



News published on and distributed by: